Brean Capital Starts MEI Pharma (MEIP) at Buy, PT $16
Tweet Send to a Friend
Brean Capital initiated coverage on MEI Pharma (NASDAQ: MEIP) with a Buy rating and price target of $16.00.
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE